Show menu

Latest news from SEQENS Group

image
OPAS SUR LES TITRES DE PCAS SA
LES DOCUMENTS ET INFORMATIONS MIS À DISPOSITION SUR CETTE PAGE SONT RELATIFS AU PROJET D’OFFRE PUBLIQUE D’ACHAT SIMPLIFIÉE INITIÉ PAR SEQENS SUR LES ACTIONS PCAS (L’« OFFRE »). Le projet d’Offre est fait exclusivement en France. Les documents et informations relatifs à l’Offre sont destinés à n’être diffusés qu’en France, à l’exclusion de tout autre pays. De … Continued
Read more
image
Smart Immune and CELLforCURE by SEQENS partner to industrialize SMART101 clinical batches manufacturing
Read more
image
[Article, Personal Care Magazine]
Read more
image
Arkema Grants an Exclusive Technology License to SEQENS to manufacture PEKK
Read more
image
Seqens women portraits: Juliette Martin, PhD
Read more
image
European Industry Summit: Pierre Luzeau, CEO of Seqens joins 73 industry leaders to call for a European Industrial Deal
Read more
image
Seqens and KK India petroleum specialties PVT LTD announce new partnership for lubricant additives in India
Read more
image
Skinification: plant polysaccharides rescue damaged hair
Read more
image
Seqens partners with Pleryon to develop and manufacture an innovative GMP Polymer to treat osteoarthritis
Read more
image
New investments in China
Read more
image
Seqens group at DCAT Week 2023
Read more
image
Seqens Group Opens Flagship Pharmaceutical R&D Center in Boston
Read more
image
Seqens chooses to reshore Paracetamol production in France : work on the future plant has begun.
Read more
1 2 3 11